Global AI-Powered Diagnostic Imaging Devices Market Size, Share & Trends Analysis Report By Modality (MRI, CT Scan, X-Ray, Ultrasound, PET/SPECT, Mammography, Nuclear Imaging), By Application (Oncology, Cardiology, Neurology, Orthopedics, Pulmonology, Gastroenterology, Women’s Health), By Technology (Deep Learning, Machine Learning, Computer Vision, Natural Language Processing, Generative AI), By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Clinics, Point-of-Care Settings), and By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America) – Forecasts, 2026–2034

Table of Contents

1. Introduction

1.1. Market Introduction

1.2. Research Methodology

1.3. Estimation Methodology

1.4. AI-Powered Diagnostic Imaging Ecosystem Overview

1.5. Market Classification & Scope

1.6. Geographic Scope

1.7. Study Years

2. Market Dynamics

2.1. Drivers: Radiologist Shortage, Rising Imaging Volumes, Clinical Workflow Optimization

2.2. Restraints: Algorithm Bias, Data Quality Challenges, Validation & Regulatory Complexity

2.3. Opportunities: Multimodal AI Platforms, Clinical Decision Support Systems, Federated Learning Frameworks

3. Market Segmentation (2026–2034)

3.1. By Modality

3.2. By Technology

3.3. By Application

3.4. By End-User

3.5. By Region

4. Regional Overview

4.1. North America

4.2. Europe

4.3. Asia Pacific

4.4. Middle East & Africa

4.5. Latin America

5. Competitive Analysis

5.1. Key Strategies

5.2. Revenue and Market Share Analysis

5.3. AI Platform & Algorithm Positioning

5.4. Product Portfolio & Clinical Validation Assessment

5.5. Partnerships, Acquisitions & Strategic Collaborations

6. Technology & Innovation Trends

6.1. Deep Learning-Based Image Interpretation

6.2. Real-Time AI Integration at Imaging Modality Level

6.3. AI-Optimized Image Acquisition & Reconstruction

6.4. Multimodal AI and Clinical Decision Support

6.5. Generative AI for Radiology Reporting

6.6. Edge AI & Cloud-Based Imaging Analytics

7. Regulatory Landscape

7.1. FDA Framework for AI-Enabled Medical Imaging Devices

7.2. European Union Medical Device Regulation (EU MDR)

7.3. AI Regulatory Frameworks in Asia-Pacific Healthcare Markets

7.4. Clinical Validation and Algorithm Transparency Requirements

7.5. Reimbursement Policies for AI-Assisted Diagnostic Imaging

8. Market Research Findings & Conclusion

9. Disclaimer